Therefore, a significant decrease in the Lrg1 expression level after Se-Met treatment of 3xTg AD mice confirmed that Se-Met has a role in alleviating the inflammation of AD, which agrees with our previous results [9,10]. This evidence concerns the gene LRG1 and Alzheimer disease.